CMS Reimbursement Code

Represented Ferring Pharmaceuticals-USA, which manufactures the first bioengineered, injectable hyaluronic acid approved by the FDA for the treatment of osteoarthritis of the knee, in reclassifying its CMS reimbursement code for the drug so that it would have the same code as its competitors.

Service Areas